Part 2 of our highlighted selection of Covid-related cross-sectional case control studies from the scientific press for January 2022
-
-
Part 1 of our highlighted selection of Covid-related cross-sectional case control studies from the scientific press for January 2022
-
Our highlighted selection of Covid-related case series and case reports from the scientific press for January 2022 -
Our highlighted selection of Covid-related expert opinions from the scientific press for January 2022 -
Our highlighted selection of miscellaneous Covid-related studies from the scientific press for January 2022 -
Our highlighted selection of Covid-related Literature Reviews from the scientific press for January 2022. -
Breaking newsStudy of mirtazapine for agitated behaviors in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
This parallel-group, double- blind, ransomised, placebo-controlled trial conducted in 26 United Kingdom centres, investigated the efficacy and tolerability of mirtazapine versus placebo in treating agitation in patients with probable or possible Alzheimer’s disease. -
This study investigated the potential benefits of smoking cessation in slowing down clinical progression in patients with multiple sclerosis.
-
Breaking newsCOVID-19
C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy
Twenty patients hospitalized with COVID-19 encephalopathy were included in this retrospective cohort study. -
Breaking newsCOVID-19
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study
In this case-control study, the authors evaluated NSSS from a cohort of 7,812,845 BNT162b2 first-dose recipients, of whom 10,929 reported an adverse event following immunization. -
This narrative review was conducted to collect and discuss published data about neurological side effects of SARS-CoV-2 vaccines in order to discover type, frequency, treatment, and outcome of these side effects.
-
The objective of this retrospective cross-sectional study was to generate real-world multiple sclerosis–specific vaccine safety information, particularly in the context of specific DMTs, and provide information to mitigate specific concerns in vaccine hesitant PwMS.
-
Breaking newsCOVID-19
Multifocal and Microvascular Involvement in Ischemic Stroke During COVID-19: A Cohort Study With Comparison With Non-COVID-19 Stroke
This single-center retrospective observational study compared stroke characteristics between patients with and without COVID-19. -
In this article the author sought to highlight the most remarkable findings concerning headache secondary to COVID-19, specifically focusing on epidemiology, characteristics, pathophysiology, and treatments.
-
Breaking newsCOVID-19
Incidence and Predictors of Thrombotic Complications in 4742 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched Study
In this study the authors retrospectively studied 4742 patients with acute infectious respiratory disease (AIRD); 2579 were diagnosed to have COVID-19 and treated with heparin, whereas 2163 had other causes of AIRD.